So, Adagrasib—this is a KRAS G12C inhibitor. It’s used to treat NSCLC. It targets those KRAS G12C mutations.
And guess what? It comes in 200mg tablets. You’re supposed to take it twice a day, 600mg each time. It doesn’t matter if you take it with or without food.Just a side note, there are 180 tablets in the pack.
Reviews
There are no reviews yet.